In turn, these changes create a condition of metabolic competition or stress wherein the anti-tumor functions of macrophages, dendritic cells (DCs), NK cells, and conventional CD4+ and CD8+ T cells are reduced as recently summarized elsewhere [1–5]. The gene discussed is CD4; the disease is neoplasm.